A Center Without Walls

We are dedicated to fostering collaboration within the field of Integrative Medicine (IM)

Connect to others with our interactive IM Research Network Map. This virtual tool is designed to help Harvard professionals connect and learn from each other.

Test drive the interactive map here.

Learn from leaders in integrative medicine through our free Integrative Medicine Research Seminar Series. (Monthly)

Dr. Peter Wayne , July, 9th, 2015
'Minding' Our Balance: How tai chi research is informing the interdependence of cognitive and motor skills in aging."

Watch Videos of the 2014/2015 Series here.

Attend monthly Integrative Medicine Grand Rounds.
Next Clinical Case Presentation: Tuesday, July 7th.
By: The Zakim Center for Integrative Therapies, DFCI.
Prostate Cancer treated with multiple IM Therapies
Watch IM Grand Rounds video presentations here.

2015 Featured Conference

News and Events

The Value of Acupuncture in Cancer Care

Weidong Lu, Lead Oncology Acupuncturist at the Zakim Center for Integrative Therapies at the Dana Farber Cancer Institute will be speaking on July 7th, 2015, along with his colleagues, at the Integrative Medicine Grand Rounds that we host at Brigham and Women’s Hospital.

Read this PMC article “The Value of Acupuncture in Cancer Care” co-authored by Lu. This article was first published in Hematology/Oncology Clinics of North America.

“In the United States, acupuncture is used to treat a variety of symptoms and conditions associated with cancer and the side effects of cancer treatments. A number of cancer centers in the U.S., including Dana-Farber Cancer Institute (DFCI) in Boston, Memorial Sloan-Kettering Cancer Center in New York, and M.D. Anderson Cancer Center in Houston are integrating acupuncture into cancer care. This trend parallels a broader trend of increasing use of Complementary and Alternative Medicine (CAM) among cancer patients, estimated in some surveys to range between 48% and 83%.

Specific use of acupuncture by cancer patients is estimated to range between 1.7% and 31%. Despite interest by conventional care providers and the public in the integration of acupuncture into cancer care, the full extent to which acupuncture can be applied to oncology care is limited by research evidence regarding its efficacy and safety in treating and preventing cancer-related symptoms.

There are a few conditions for which sound research has demonstrated acupuncture to be an effective and safe adjunct therapy for cancer care. Randomized clinical trials (RCT) have demonstrated that acupuncture is effective for chemotherapy-induced nausea and vomiting. Research studies also suggest acupuncture may be helpful in managing cancer-related pain, chemotherapy-related neutropenia, cancer fatigue, and radiation-induced xerostomia.

Acupuncture, an ancient medical treatment originating in China, is gaining momentum and acceptance as a valid intervention in medical practice. In the past decade acupuncture and other integrative medicine programs have been established in many major medical centers in the United States.

For example in November 2000, the Leonard P. Zakim Center for Integrative Therapies (Zakim Center) was established at DFCI, a teaching hospital of Harvard Medical School, to provide complementary therapies to patients of DFCI. The Zakim Center is named in memory of Lenny Zakim, a cancer patient and advocate for an integrative approach to cancer treatment. The mission of the Center is to educate and empower patients and staff by integrating the practice of complementary therapies into traditional cancer treatments.”

Read the full author manuscript here.

This November 14th, the Osher Center will be bringing together three different societies to investigate the intersection between Oncology, Acupuncture and Fascia research.

Learn more about the Joint Conference on Acupuncture, Oncology and Fascia here.

ABC News hosts NCCIH Twitter Chat

Earlier this week, Dr. Peter Wayne, Research Director of the Osher Center, shared his expert knowledge in bite size pieces on a live Twitter Chat hosted by ABC News: Complimentary and Integrative Health: What does the Science Say?

Dr. Wayne tweeted using the @BrighamWomens handle.

The following themes were discussed:

T1: “What do we mean by complementary, alternative and integrative health care?”
T2: “Who uses complementary and Integrative Health approaches? How has it changed over time?”
T3: “Should complementary medicine approaches be held to the same scientific standards as conventional medicine? Why or why not?”

Read the Full Chat Transcript Here.

View Chat by Slide Show below

Notable tweeters included Director, Dr. Josephine Briggs, and Branch Chief of Basic and Mechanistic Research, John Williamson, of the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH), the leading Federal agency for research on integrative and complementary health practices.

Other  institutions taking part included our sister Osher Center at the University of California in San Francisco, The Cleveland Clinic, Stanford Medical School, The National Cancer Institute, and many others.

JoAnn Manson on Vitamin D Dosage – Osher Research Seminar

Earlier this month, Dr. JoAnn Manson, Division Chief of Preventive Medicine at Brigham and Women’s Hospital, gave an in-depth presentation about clinical research surrounding safe and beneficial Vitamin D dosage. Watch the presentation here.

Dr. Manson was recently featured  in TIME Magazine regarding the variable clinical research findings regarding Vitamin D levels.

“Clinicians are often left chasing a number, and trying to get patients’ blood levels up to a certain point,” says Manson. “But when you think about how many people are screened for vitamin D, and the concerns about the reliability in how it’s measured, and the differences in what is considered normal ranges across laboratories, it’s really concerning.” Read the Full article here.

JoAnn at podium 586x419
In this presentation, Dr. Manson discusses the international randomized trial being conducted by Brigham and Women’s Hospital to evaluate the health benefits of different dosage levels of vitamin D: The large-scale VITamin D and OmegA-3 TriaL (VITAL). This is the largest of its kind, with 26,000 participants from across the U.S., Europe, Australia and New Zealand.